Skip to main content

Table 2 Characteristics of trusts participating in interviews vs. all trial trusts

From: How do hospital professionals involved in a randomised controlled trial perceive the value of genotyping vs. PCR-ribotyping for control of hospital acquired C. difficile infections?

  Interview group Trial population All trusts in trial
  MLVA Ribotyping MLVA Ribotyping  
Number Trusts Interviewed 5 6 NA NA NA
Hospital isolation facilities      
Average bed size 1,056 977 922 912 902
Single rooms with en-suite (% total beds) 10% 10% 14% 13% 12%
Single rooms without en-suite (% total beds) 10% 6% 10% 7% 5%
Average typing test requests over 12 months      
Test requests (mean number/trust) 56.0 61.5 66.8 58.6 50.4
All post 48 hr C difficile cases reported over 12 months    814 868 1,682